Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Lorena Baboci"'
Autor:
Lorenzo Vinante, Jayant Sharad Vaidya, Angela Caroli, Mario Mileto, Erica Piccoli, Michele Avanzo, Loredana Barresi, Marta Marson, Marcella Montico, Lorena Baboci, Tiziana Perin, Martina Urbani, Fabio Puglisi, Maurizio Mascarin, Samuele Massarut
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRandomised evidence supports the use of partial breast irradiation (PBI) with targeted intraoperative radiotherapy (TARGIT-IORT) for early stage breast cancer, but prospective data from real-world adoption of this technique is also import
Externí odkaz:
https://doaj.org/article/20f6c6e23eeb450da713491986d44754
Autor:
Lorenzo Vinante, Angela Caroli, Alberto Revelant, Federica Bertini, Anna Giroldi, Marta Marson, Giovanni Franchin, Elena Muraro, Giulia Brisotto, Agostino Steffan, Lorena Baboci
Publikováno v:
Breast, Vol 65, Iss , Pp 49-54 (2022)
Background: and purpose: Radiation recall dermatitis is an adverse event predominantly due to systemic therapy administration after a previous radiation therapy course. Few case reports describe radiation recall dermatitis in breast cancer patients t
Externí odkaz:
https://doaj.org/article/3ca7c78b23ee4d00b2f08db5ef8c6fc2
Autor:
Jerry Polesel, Anna Menegaldo, Giancarlo Tirelli, Vittorio Giacomarra, Roberto Guerrieri, Lorena Baboci, Mariateresa Casarotto, Valentina Lupato, Giuseppe Fanetti, Paolo Boscolo-Rizzo, Elisabetta Fratta
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundAt present, the prognostic significance of programmed cell death receptor ligand 1 (PD-L1) expression in oropharyngeal squamous cell carcinoma (OPSCC) patients is still controversial. In this study, we aim to synthesize relevant studies tha
Externí odkaz:
https://doaj.org/article/42baa9d1310a49438240d160ce7c4fb3
Autor:
Federica Di Cintio, Michele Dal Bo, Lorena Baboci, Elena De Mattia, Maurizio Polano, Giuseppe Toffoli
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Glioblastoma (GBM) is the most frequent and aggressive primary central nervous system tumor. Surgery followed by radiotherapy and chemotherapy with alkylating agents constitutes standard first-line treatment of GBM. Complete resection of the GBM tumo
Externí odkaz:
https://doaj.org/article/90cd324f47844a6db5222c81e4f69625
Autor:
Lorena Baboci, Dana Holzinger, Paolo Boscolo-Rizzo, Giancarlo Tirelli, Roberto Spinato, Valentina Lupato, Roberto Fuson, Markus Schmitt, Angelika Michel, Gordana Halec, Maria Cristina Da Mosto, Michael Pawlita, Annarosa Del Mistro
Publikováno v:
Papillomavirus Research, Vol 2, Iss , Pp 133-140 (2016)
Objectives: To investigate the frequency of Human papillomavirus (HPV)-driven head and neck squamous cell carcinoma (HNSCC) among patients living in North-East Italy, by assessing HPV-DNA positivity in all tumors and additional markers whenever possi
Externí odkaz:
https://doaj.org/article/c445cc3d74814f07b9743dde41d9694a
Autor:
Elena Muraro, Lorenzo Vinante, Elisabetta Fratta, Alessandra Bearz, Daniela Höfler, Agostino Steffan, Lorena Baboci
Publikováno v:
Cancers. 15:2471
Increasing evidence pinpoints metronomic chemotherapy, a frequent and low dose drug administration with no prolonged drug-free intervals, as a potential tool to fight certain types of cancers. The primary identified targets of metronomic chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a129a7ccd41a3f6ab4b726046c7e5daf
https://doi.org/10.3390/cancers15092471
https://doi.org/10.3390/cancers15092471
Autor:
Mariateresa Casarotto, Valentina Lupato, Giorgio Giurato, Roberto Guerrieri, Sandro Sulfaro, Annamaria Salvati, Elisa D'Angelo, Carlo Furlan, Anna Menegaldo, Lorena Baboci, Barbara Montico, Irene Turturici, Riccardo Dolcetti, Salvatore Romeo, Vittorio Baggio, Stefania Corrado, Gianluca Businello, Maria Guido, Alessandro Weisz, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Luca Sigalotti, Emanuela Vaccher, Paolo Boscolo-Rizzo, Jerry Polesel, Giuseppe Fanetti, Elisabetta Fratta
Publikováno v:
Cancer Research. 83:1005-1005
Background: Currently, human papillomavirus (HPV) positivity represents a strong prognostic factor for both reduced risk of relapse and improved survival in patients with oropharyngeal squamous cell carcinoma (OPSCC). However, a subset of HPV-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bfa3f63b491b8826f9ecae1e04a8e37
https://doi.org/10.1158/1538-7445.am2023-1005
https://doi.org/10.1158/1538-7445.am2023-1005
Autor:
Barbara Montico, Giorgio Giurato, Roberto Guerrieri, Annamaria Salvati, Francesca Colizzi, Lorena Baboci, Luca Sigalotti, Alessia Covre, Michele Maio, Agostino Steffan, Tuula A. Nyman, Alessandro Weisz, Maurizio Mongiat, Eva Andreuzzi, Elisabetta Fratta
Publikováno v:
Cancer Research. 83:4806-4806
Introduction: At present, the precise role of Spry proteins in tumor progression is still debated. Our previous study showed that Spry1 knockdown (Spry1KO) in BRAFV600-mutant cutaneous melanoma (CM) promoted cell cycle arrest and apoptosis, repressed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca787153c144ae03185226c54c9532bf
https://doi.org/10.1158/1538-7445.am2023-4806
https://doi.org/10.1158/1538-7445.am2023-4806
Autor:
Paolo Macor, Monica Argenziano, Federica Di Cintio, Michele Dal Bo, Giuseppe Toffoli, Federico Colombo, Prisca Mauro, Roberta Cavalli, Lorena Baboci, Sara Capolla
Publikováno v:
Journal of Oncology, Vol 2020 (2020)
Journal of Oncology
Journal of Oncology
The development of nanostructures for therapeutic purpose is rapidly growing, following the results obtained in vivo in animal models and in the clinical trials. Unfortunately, the potential therapeutic efficacy is not completely exploited, yet. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f59a15f29b7b98737cc67568c50ff485
https://doi.org/10.1155/2020/4638192
https://doi.org/10.1155/2020/4638192
Autor:
Mariateresa Casarotto, Valentina Lupato, Giorgio Giurato, Roberto Guerrieri, Sandro Sulfaro, Annamaria Salvati, Elisa D’Angelo, Carlo Furlan, Anna Menegaldo, Lorena Baboci, Barbara Montico, Irene Turturici, Riccardo Dolcetti, Salvatore Romeo, Vittorio Baggio, Stefania Corrado, Gianluca Businello, Maria Guido, Alessandro Weisz, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Luca Sigalotti, Emanuela Vaccher, Paolo Boscolo-Rizzo, Polesel Jerry, Giuseppe Fanetti, Elisabetta Fratta
Background and purpose Currently, human papillomavirus (HPV) positivity represents a strong prognostic factor for both reduced risk of relapse and improved survival in patients with oropharyngeal squamous cell carcinoma (OPSCC). However, a subset of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120b4b67ba7cda312909e192fb376212
https://hdl.handle.net/11368/3036391
https://hdl.handle.net/11368/3036391
